Comprehensive Reports and Expert Commentaries on the Latest Advances in Cancer Treatment from the 42nd Annual Meeting of the American Society of Clinical Oncology in Atlanta, Georgia PDF Download

Author: American Society of Clinical Oncology
Publisher:
ISBN:
Category :
Languages : en
Pages :

View

Book Description

Author:
Publisher:
ISBN:
Category :
Languages : en
Pages : 60

View

Book Description

Author: American Association for Cancer Research
Publisher:
ISBN:
Category :
Languages : en
Pages : 0

View

Book Description
Transformative research and technological innovations are driving unprecedented progress against the collection of diseases we call cancer. As the first and largest professional organization in the world dedicated to advancing all areas of cancer research and patient care, AACR has been and continues to be a catalyst for scientific breakthroughs that save and enhance the lives of cancer patients. It is also committed to increasing public understanding of cancer and advocating for increased federal funding for cancer research and related sciences. The annual AACR Cancer Progress Report to Congress and the American public is a cornerstone of AACR's educational efforts. This twelfth edition of the report highlights how research continues to extend and improve lives, including the lives of the five courageous individuals featured in the report and their family members who have shared their experiences with cancer. It also underscores how unwavering, bipartisan support from Congress, in the form of robust and sustained annual increases in funding for NIH, NCI, CDC, and FDA, is urgently needed if we are to realize our vision of eradicating cancer for all populations. The remarkable progress being made against cancer-in particular, improvements in reducing smoking rates and developments in early detection and treatment-is resulting in a steady fall in cancer death rates, and a consistent rise in the number of people who live longer after a cancer diagnosis. In fact, in the United States, the age-adjusted overall cancer death rate has been declining since the 1990s, with the reductions between 1991 and 2019 translating into nearly 3.5 million cancer deaths avoided. Additionally, the number of cancer survivors living in the United States has exceeded 18 million as of January 1, 2022. Unfortunately, certain U.S. populations, including racial and ethnic minorities and several other medically underserved groups, have not benefited equally from the advances against cancer. Complex factors referred to as social determinants of health have contributed to cancer health disparities in the United States. It is imperative that all stakeholders work together to eradicate the systemic and structural injustices that are current barriers.

Author: American Association for Cancer Research
Publisher:
ISBN:
Category :
Languages : en
Pages : 0

View

Book Description
Unprecedented progress in medical research is increasing our understanding of the collection of diseases we call cancer and is driving improvements in cancer prevention, early detection, diagnosis, and treatment. These advances are made possible by investments in NIH, NCI, FDA, and CDC by the U.S. federal government. As the first and largest professional organization in the world dedicated to preventing and curing all cancers, AACR continues to be a catalyst for scientific breakthroughs that save the lives of patients with cancer. AACR is committed to increasing public understanding of cancer and advocating for increased funding for medical research.The annual AACR Cancer Progress Report to Congress and the American public is a cornerstone of AACR's educational efforts. This thirteenth edition of the report highlights how research continues to extend and improve the lives of Americans, including the lives of the eight courageous individuals featured in the report and their family members who have shared their experiences with cancer. It also underscores how unwavering, bipartisan support from Congress, in the form of robust and sustained annual increases in funding for NIH, NCI, FDA, and CDC, is urgently needed.The remarkable progress being made against cancer is resulting in a steady reduction in cancer death rates, and a consistent rise in the number of people who live longer and fuller lives after a cancer diagnosis. In fact, the overall U.S. cancer death rate has fallen by 33 percent between 1991 and 2020, a reduction that translates into averting an estimated 3.8 million deaths from cancer. The reduction in overall cancer mortality is driven largely by the decline in the U.S. lung cancer death rate, the pace of which has accelerated in recent years because of reduction in smoking and advances in early detection and treatment. Additionally, the reduction in death rates for melanoma, colorectal cancer, prostate cancer, and female breast cancer has contributed to the progress against overall U.S. cancer mortality. Notably, among U.S. children and adolescents, overall cancer death rates have declined by 70 percent and 64 percent, respectively, over the past five decades.

Author: Ken O'Byrne
Publisher:
ISBN: 0198529309
Category : Medical
Languages : en
Pages : 475

View

Book Description
This book provides health professionals and scientists with a comprehensive overview of the mesothelioma - an asbestos induced malignancy. It includes chapters on epidemology, diagnosis, histopathology, radiology, surgery, chemotherapy, immune therapy, and radiotherapy as well as the molecular biology and future therapies.

Author: Guy B. Faguet
Publisher: Springer Science & Business Media
ISBN: 1402036175
Category : Medical
Languages : en
Pages : 225

View

Book Description
After reviewing the history of cancer and its impact on the population, Dr. Faguet exposes the antiquated notions that have driven cancer drug development, documents the stagnation in treatment outcomes despite major advances in cancer genomics and growing NCI budgets, and identifies the multiple factors that sustain the status quo. He shows that, contrary to frequent announcements of breakthroughs, our current cancer control model cannot eradicate most cancers and the reasons why. Significantly, this book also delineates a way forward via a shift from the discredited cell-kill approach of the past to an integrated, evidence-driven cancer control paradigm based on prevention, early diagnosis, and pharmacogenomics. The author's views are based on data published in mainstream scientific journals and other reliable references, 432 of which are cited.

Author: National Research Council
Publisher: National Academies Press
ISBN: 0309101239
Category : Medical
Languages : en
Pages : 196

View

Book Description
This report of the proceedings of a symposium held in conjunction with the release of the IOM report, From Cancer Patient to Cancer Survivor: Lost in Transition, represents an effort on the part of the American Society of Clinical Oncology (ASCO), the National Coalition for Cancer Survivorship (NCCS), and the Institute of Medicine (IOM) to further disseminate the findings and recommendations of the IOM report and to take the next step toward implementation of those recommendations. The symposium and this report serve as important vehicles to raise awareness, fill gaps that have existed in cancer patients' long-term care, and chart a course for quality care for cancer survivors and their families. More than 100 stakeholders in the cancer community, including survivors, advocates, healthcare providers, government officials, insurers and payers, and researchers participated in the symposium. This report culminates a series of work at the IOM focused on cancer survivorship. The idea to embark on a major study of cancer survivorship within the National Academies originated with the National Cancer Policy Board (NCPB). The NCPB was established in 1997 in the IOM and the National Research Council's Division of Earth and Life Studies at the request of the National Cancer Institute (NCI), the National Institutes of Health, and the President's Cancer Panel. The NCPB identified emerging policy issues in the nation's effort to combat cancer, and prepared reports that address those issues, including a series of reports on topics ranging from cancer prevention to end-of-life care.

Author: American Association for Cancer Research
Publisher: CTI Meeting Technology
ISBN: 1005543747
Category : Health & Fitness
Languages : en
Pages : 3696

View

Book Description
The AACR Annual Meeting is the focal point of the cancer research community, where scientists, clinicians, other health care professionals, survivors, patients, and advocates gather to share the latest advances in cancer science and medicine. From population science and prevention; to cancer biology, translational, and clinical studies; to survivorship and advocacy; the AACR Annual Meeting highlights the work of the best minds in cancer research from institutions all over the world.

Author: Donald L. Trump
Publisher: Rowman & Littlefield
ISBN: 1538144905
Category : Health & Fitness
Languages : en
Pages : 313

View

Book Description
A 2022 Choice Reviews Outstanding Academic Title An important history of the development of cancer centers of excellence and the revolution in cancer treatment. In the 1960s a coalition of concerned citizens, scientists and politicians joined forces to convince the federal government to focus its efforts on conquering cancer. The National Cancer Act of 1971 resulted and was signed into law on December 23, 1971 by President Nixon. The national “War on Cancer,” was declared with some leaders naively arguing that the disease would be conquered by the nation’s bicentennial—a mere five years in the future. Over the next five decades scientific discoveries demonstrated the great complexity of what had formerly been thought of as a single disease – with the advent of the genetic characterization of cancers, it is now recognized that there are almost an infinite number of cancers as defined by their many genetic mutations. The National Cancer Act established the infrastructure for the designation of centers by the National Cancer Institute (NCI) and these centers have evolved into models of multidisciplinary, collaborative cancer research, treatment and prevention contributing to a reduction in cancer mortality and increase in quality of life and survival that has translated into more than 17 million cancer survivors in the United States in 2021. Centers of the Cancer Universe: A Half-Century of Progress Against Cancer tells the story of how cancer research was not front and center at most universities and research institutions before the National Cancer Act of 1971, and why many physicians were reluctant even to treat patients with cancer in the early 20th century. It follows the behind-the-scenes lobbying, resistance and negotiating that preceded signing the Act into law, and how the cancer centers of today came to fruition, and shaped how cancer research, clinical trials and treatment would be conducted.

Author: Bernd Alt-Epping
Publisher: Springer
ISBN: 3662462028
Category : Medical
Languages : en
Pages : 302

View

Book Description
Palliative care provides comprehensive support for severely affected patients with any life-limiting or life-threatening diagnosis. To do this effectively, it requires a disease-specific approach as the patients’ needs and clinical context will vary depending on the underlying diagnosis. Experts in the field of palliative care and oncology describe in detail the needs of patients with advanced cancer in comparison to those with non-cancer disease and also identify the requirements of patients with different cancer entities. Basic principles of symptom control are explained, with careful attention to therapy for pain associated with either the cancer or its treatment and to symptom-guided antineoplastic therapy. Complex therapeutic strategies for palliative cancer patients are highlighted that involve both cancer- and symptom-directed options and address a range of therapeutic aims. Issues relating to drug use in palliative cancer care are fully explored, and a separate section is devoted to care in the final phase. A range of organizational and policy issues are also discussed, and the book concludes by considering likely future developments in palliative care for cancer patients. Palliative Care in Oncology will be of particular interest to palliative care physicians who are interested in broadening the scope of their disease-specific knowledge, as well as to oncologists who wish to learn more about modern palliative care concepts relevant to their day-to-day work with cancer patients.